|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
13
|
|
pubmed:dateCreated |
2007-7-4
|
|
pubmed:abstractText |
Recent reports have identified an association between osteonecrosis of the jaw or facial bones and treatment with nitrogen-containing intravenous bisphosphonates. We investigated this association by use of data from the Surveillance, Epidemiology, and End Results (SEER) program linked to Medicare claims.
|
|
pubmed:grant |
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
1460-2105
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
4
|
|
pubmed:volume |
99
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1016-24
|
|
pubmed:dateRevised |
2008-1-28
|
|
pubmed:meshHeading |
pubmed-meshheading:17596574-Aged,
pubmed-meshheading:17596574-Aged, 80 and over,
pubmed-meshheading:17596574-Bone and Bones,
pubmed-meshheading:17596574-Diphosphonates,
pubmed-meshheading:17596574-Female,
pubmed-meshheading:17596574-Humans,
pubmed-meshheading:17596574-Inflammation,
pubmed-meshheading:17596574-Jaw Diseases,
pubmed-meshheading:17596574-Male,
pubmed-meshheading:17596574-Medicare,
pubmed-meshheading:17596574-Middle Aged,
pubmed-meshheading:17596574-Neoplasms,
pubmed-meshheading:17596574-Osteonecrosis,
pubmed-meshheading:17596574-SEER Program,
pubmed-meshheading:17596574-United States
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
Intravenous bisphosphonate therapy and inflammatory conditions or surgery of the jaw: a population-based analysis.
|
|
pubmed:affiliation |
Department of Preventive Medicine and Community Health, University of Texas Medical Branch, 301 University Blvd, Galveston, TX 77555-1153, USA. gswilkin@utmb.edu
|
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, N.I.H., Extramural
|
